Appointment booking for Dr. Barbara Baxter, MD is currently not available.Dr. Barbara Baxter, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Barbara Baxter, MD (she/her) is a Allergist in Dallas, TX with over 18 years of experience. What is your opinion of Dr. Barbara Baxter, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Barbara Baxter, MD has received over $4,057 which includes payments from the following companies:
$844.85 from AstraZeneca UK Limited
$612.45 from CSL Behring
$554.63 from AstraZeneca Pharmaceuticals LP
$305.43 from Meda Pharmaceuticals, Inc.
$192.99 from Grifols USA, LLC
$169.78 from Merck Sharp & Dohme Corporation
$159.27 from ALK-Abello, Inc
$146.70 from GENZYME CORPORATION
$142.88 from GlaxoSmithKline, LLC.
$86.88 from Mylan Specialty L.P.
$82.57 from Regeneron Healthcare Solutions, Inc.
$79.53 from LILLY USA, LLC
$74.47 from Octapharma USA, Inc.
$73.39 from Pfizer Inc.
$73.36 from Kaleo, Inc.
$65.00 from AstraZeneca AB
$63.96 from Genentech USA, Inc.
$57.52 from Baxalta US Inc
$54.15 from Teva Pharmaceuticals USA, Inc.
$53.70 from sanofi-aventis U.S. LLC
Payments received by Dr. Barbara Baxter, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!